COVID Prevention and Treatment Trials

Learn more about clinical trials for COVID-19 Prevention

Johns Hopkins is working with many research teams to understand how the COVID-19 virus causes disease, how we might fight the virus, and how to develop better treatments and vaccines. Participation in a clinical trial is voluntary. If you decide not to be part of a study, it will not change the medical care you receive.

PI: Dr. Mark Sulkowski
Call or Text: 410-314-1142
The PROTECT study is recruiting household contacts of people who have been diagnosed with
SARS-CoV-2 infection for a research study of use of an investigational drug Interferon Lambda,
also called “Lambda”, in the prevention of COVID-19 illness.

Persons who are aged 18-80 who have a household member who has been
diagnosed with COVID-19 might be eligible.

Study Location: Johns Hopkins Greenspring Station Clinical Research Unit,
Lutherville, MD. Compensation: Up to $100 as a gift card if all visits are completed.

Duration of participation: 1 days of dosing, 4 weeks in total including follow-up.

To Learn More About Clinical Trials for COVID-19

Prevention & Treatment Visit Trials@Hopkins